Liquid biopsy, a blood-based testing approach, could help doctors make more precise treatment decisions by identifying cancer-related information in the bloodstream.
Pharma companies delivered contrasting earnings signals this week, with some reporting sharp profit declines while others recorded strong growth.
Two new studies published in JAMA and JAMA Pediatrics reveal a clear rise in infant bleeding cases linked to vitamin K deficiency.
AbbVie expands Oxford research capabilities, strengthening drug discovery through biotechnology expertise, academic partnerships and new disease target exploration.
In an exclusive interaction with Zeenat Parween, Sr. Correspondent at India Pharma Outlook, Abdullah Azam, Founder and CEO, Akatalyst Technologies, discusses the growing role of AI in pharmaceutical quality management, its potential to strengthen...
Sino Biopharmaceutical’s USD 7 billion oncology agreement highlights preclinical oncology licensing and the company's expanding strategy of partnering its drug pipeline with global pharmaceutical groups.
Kapiva takes science-backed Ayurveda into Cult Neo’s fitness ecosystem, expanding natural wellness, nutrition, and recovery support across 250 gyms nationwide.
Wockhardt seeks 14-year regulatory data protection for local drug research, raising questions about innovation incentives, regulatory delays, and patient access.
Weight loss injections may ease PMOS symptoms and improve metabolic health, but experts warn they cannot cure underlying hormonal imbalances.
India's healthcare industry faces three defining shifts as drug pricing, weight-loss innovation, and pharmaceutical R&D reshape patient access and competition.
.jpg)
, CDSCO.jpg)
